InsiderPulse| Trade Date | Filed | Owner | Role | Type | Shares | Price | Value | Owned After | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-06 | 2026-03-09 | ARCH Venture Partners IX, LLC | 10% Owner | Purchase | 488.1K | $25.61 | $12.50M | 1.43M | View ↗ | |
| 2026-02-11 | 2026-02-12 | Seely Lynn | Director & President and CEO | Sale | 7,455 | $23.39 | $174K | 74.3K | View ↗ | |
| 2026-02-11 | 2026-02-12 | Hill Stephen J. | Chief Operating Officer | Sale | 1,236 | $23.39 | $29K | 17.8K | View ↗ | |
| 2026-02-11 | 2026-02-12 | Lee Gary K. | Chief Scientific Officer | Sale | 1,671 | $23.39 | $39K | 16.9K | View ↗ | |
| 2026-02-10 | 2026-02-11 | Hill Stephen J. | Chief Operating Officer | Sale | 109 | $23.12 | $3K | 19.0K | View ↗ |
No annual data found.
Lyell Immunopharma reports Q1 results
Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026
Lyell Immunopharma, Inc. (LYEL) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
A First Look At Lyell Immunopharma